2022 Spring-Summer

The Once for Wales Concerns Management System (Datix Cymru) has recently been made available for all community pharmacy contractors, as a successor to the National Reporting and Learning System (NRLS) which has been decommissioned. All patient safety incidents are reported to the relevant Health Board in NHS Wales, using this system from 1 April 2022.

Join us on this webinar to understand more about the changes including practical information and resources to support you in this aspect of your roles.

While COVID-19 symptoms pass quickly for most, some people are suffering ongoing effects. As time passes, we are learning more about these effects and why some people experience them and some do not. Join us on this collaborative webinar organised by the GP and Pharmacy CPD teams within HEIW, for an update on Long COVID and how we can support our patients across Wales.

Antibiotics are an important tool for the treatment of certain bacterial infections and are mainly used as short courses. However, in some situations, patients may require longer treatment courses, stand-by/rescue treatment or as a prophylactic agent to prevent infection.

Antibiotic resistance is an increasing problem in healthcare today. Therefore, the prudent and appropriate use of long term/prophylactic antibiotics is more important than ever. We all have a role to play in ensuring our patients have the appropriate treatment while being mindful of the challenge antibiotic resistance poses to healthcare today.

Join our panel of specialist Antimicrobial Pharmacists on this webinar to understand the background to their use and evidence for appropriate prescribing. The focus of the session will be around the appropriate management and review of patients on long-term/prophylactic antibiotics.

The Direct oral anticoagulants; apixaban, dabigatran, edoxaban and rivaroxaban have been around for some years now. Despite this they are still sometimes referred to as ‘Novel’ or ‘New’ oral anticoagulants (NOACs). Their use is increasing, and NICE Guidance published last year now recommends them first line over warfarin for patients with atrial fibrillation. Join us on this webinar to ensure you are up to date with all the latest developments, including when to use, which to choose as well as differences between the use of DOACs and warfarin, to be able to best support patients using these medicines.

The thyroid gland hormones regulate the body’s metabolism and affect growth and development, while the parathyroid glands regulate calcium levels. Several disorders can affect the function of the glands leading to adverse effects.  This focal point will concentrate on the management of these disorders, including, symptoms, testing and medical and non-medical interventions.

The thyroid gland hormones regulate the body’s metabolism and affect growth and development, while the parathyroid glands regulate calcium levels. Several disorders can affect the function of the glands leading to adverse effects.  This focal point will concentrate on the management of these disorders, including, symptoms, testing and medical and non-medical interventions.

The thyroid gland hormones regulate the body’s metabolism and affect growth and development, while the parathyroid glands regulate calcium levels. Several disorders can affect the function of the glands leading to adverse effects.  This focal point will concentrate on the management of these disorders, including, symptoms, testing and medical and non-medical interventions.

The thyroid gland hormones regulate the body’s metabolism and affect growth and development, while the parathyroid glands regulate calcium levels. Several disorders can affect the function of the glands leading to adverse effects.  This focal point will concentrate on the management of these disorders, including, symptoms, testing and medical and non-medical interventions.

The thyroid gland hormones regulate the body’s metabolism and affect growth and development, while the parathyroid glands regulate calcium levels. Several disorders can affect the function of the glands leading to adverse effects.  This focal point will concentrate on the management of these disorders, including, symptoms, testing and medical and non-medical interventions.